Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-40.17	39.77	66.47
Graham Fair Price	63.76	1748.60	1067.81
PEG	-77.15	0.06	0.27
Price/Book	32.09	1.44	1.09
Price/Cash Flow	-51.01	26.29	-53.66
Prices/Earnings	-44.53	9.49	17.12
Price/Sales	-18.02	5.97	7.28
Price/FCF	-51.01	26.29	-53.66
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	12.69	0.28	0.25
Operating Margin	36.56	0.23	0.17
ROA	151.51	0.01	< 0.005
ROE	0.02	0.04	138.15
ROIC	< 0.005	0.02	138.53
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.06	0.04	46.37
Dividends QOQ	583.11	-1.00	-99.83
EBIT QOQ	0.35	1.33	282.78
EPS QOQ	0.63	1.53	142.72
FCF QOQ	-0.93	3.86	316.37
Revenue QOQ	0.15	0.71	386.07
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	225.44	111.63	-50.48
Days Sales Outstanding (DSO)	17.50	14.98	-14.37
Inventory Turnover	0.40	0.81	101.95
Debt/Capitalization	0.60	0.57	-5.03
Quick Ratio	1.34	1.53	14.66
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1785.62	1894.80	6.11
Cash	997.38	979.19	-1.82
Capex	-87.38	-130.52	-49.37
Free Cash Flow	-36.21	103.61	186.13
Revenue	266.86	456.29	70.99
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.10	2.23	6.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	36.60	18.03	-50.73
Naive Interpretation	Member

06 - Financial Health · Bad

Rating